logo


Eclipsys Recognized by KLAS as Leading in Physician CPOE Adoption
Wednesday, June 10, 2009 8:36 AM


With the most physicians, highest satisfaction and percentage of clients deeply using electronic order entry in acute care hospitals, company cited as well-positioned to meet the ARRA meaningful use criteria

Underscoring its strong industry position to help healthcare organizations achieve “meaningful use,” Eclipsys Corporation® (NASDAQ: ECLP), The Outcomes Company®, today announced that KLAS has reported that the company leads the industry in the number of physicians using its computerized physician order entry (CPOE) system in acute care hospitals and the percentage of its client base deeply using CPOE. The company also has the highest physician satisfaction from clients using its Sunrise Acute Care™ solution.

The recently enacted American Recovery and Reinvestment Act of 2009 (ARRA) offers federal incentives to hospitals and providers for achieving “meaningful use of an electronic health record (EHR).” ARRA also has stirred debate as to whether a specific EHR technology can deliver the level of clinician adoption required to surpass the required threshold of “meaningful use.”

According to the recently issued KLAS “Meaningful Use Leading to Improved Outcomes” report, deep adoption is pivotal to the overarching success of an electronic medical record (EMR) implementation. The KLAS report noted Eclipsys is among the vendors that are by far the most successful with regard to physician adoption, and that survey respondents cited the company as able to provide an integrated ambulatory EMR solution to the marketplace that is well-positioned to meet the meaningful use criteria.

In addition, KLAS concluded that Eclipsys has an advantage in both physician satisfaction and time required to order with the company’s CPOE system.



(0)
No Comments
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

  
Related Press Releases
Advertisement
Popular Articles
Advertisement
Partner Center
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia